Literature DB >> 24923704

High prevalence of non-alcoholic fatty liver disease in the Chinese - results from the Hong Kong liver health census.

James Fung1, Cheuk-Kwong Lee, Monica Chan, Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen.   

Abstract

BACKGROUND & AIMS: The prevalence of non-alcoholic fatty liver disease (NAFLD) in the general Chinese population is not clear, as there have been few large population studies focussing on healthy individuals. We aim to determine the prevalence and risk factors of NAFLD in a healthy Westernized Chinese population.
METHODS: This is a prospective cross-sectional study of 2493 volunteers recruited from the general population and the Red Cross Transfusion Center in Hong Kong. All underwent comprehensive questionnaire survey, blood test, abdominal ultrasound and transient elastography.
RESULTS: The prevalence of NAFLD was 42%. Gender, age, waist circumference, systolic blood pressure, fasting cholesterol and glucose levels were significant factors. The relative risk of NAFLD in those with high waist circumference, diabetes, hypertension, and hypercholesterolaemia was 2.99, 2.01, 1.79 and 1.54 respectively. The degree of steatosis increased with levels of fasting glucose, cholesterol, systolic blood pressure and waist circumference (all P < 0.001). The optimal waist circumference was found to be 84 and 74 cm for male and females respectively, with a relative risk of 5.16 for those above this limit. In total, 1.2% and 0.002% with NAFLD had advanced liver fibrosis and cirrhosis respectively.
CONCLUSION: Non-alcoholic fatty liver disease was found to be highly prevalent in the Chinese population. Increasing levels of risk factors were associated with increasing severity of NAFLD. Lower cut-off levels of waist circumference to predict NAFLD should be adopted for Chinese population.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NAFLD; prevalence; steatosis

Mesh:

Substances:

Year:  2014        PMID: 24923704     DOI: 10.1111/liv.12619

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  24 in total

1.  Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.

Authors:  Robert J Pattison; James Phillip Esteban; Tomoki Sempokuya; Jakrin Kewcharoen; Sumodh Kalathil; Scott K Kuwada
Journal:  Hawaii J Health Soc Welf       Date:  2020-06-01

2.  Managing non-alcoholic fatty liver disease.

Authors:  Jing Hieng Ngu; George Boon Bee Goh; Zhongxian Poh; Roy Soetikno
Journal:  Singapore Med J       Date:  2016-07       Impact factor: 1.858

3.  Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection.

Authors:  Lung-Yi Mak; Rex Wan-Hin Hui; James Fung; Fen Liu; Danny Ka-Ho Wong; Bofei Li; Ka-Shing Cheung; Man-Fung Yuen; Wai-Kay Seto
Journal:  Hepatol Int       Date:  2021-06-21       Impact factor: 6.047

4.  Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.

Authors:  Kentaro Oniki; Junji Saruwatari; Tomoko Izuka; Ayami Kajiwara; Kazunori Morita; Misaki Sakata; Koji Otake; Yasuhiro Ogata; Kazuko Nakagawa
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

5.  Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study.

Authors:  Sheng-Jie Wu; Gui-Qi Zhu; Bo-Zhi Ye; Fan-Qi Kong; Zai-Xing Zheng; Hai Zou; Ke-Qing Shi; Lu Lin; Martin Braddock; Wei-Jian Huang; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.

Authors:  Kuen Cheh Yang; Hui-Fang Hung; Chia-Wen Lu; Hao-Hsiang Chang; Long-Teng Lee; Kuo-Chin Huang
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

7.  Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease.

Authors:  Sheng-Jie Wu; Hai Zou; Gui-Qi Zhu; Li-Ren Wang; Qi Zhang; Ke-Qing Shi; Ji-Bo Han; Wei-Jian Huang; Martin Braddock; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

8.  Factors Significantly Associated With the Increased Prevalence of Carotid Atherosclerosis in a Northeast Chinese Middle-aged and Elderly Population: A Cross-sectional Study.

Authors:  Xi-Feng Pan; Ya-Xin Lai; Jian-Qiu Gu; Hao-Yu Wang; Ai-Hua Liu; Zhong-Yan Shan
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

9.  Docosahexaenoic Acid Ameliorates Fructose-Induced Hepatic Steatosis Involving ER Stress Response in Primary Mouse Hepatocytes.

Authors:  Jinying Zheng; Chuan Peng; Yanbiao Ai; Heng Wang; Xiaoqiu Xiao; Jibin Li
Journal:  Nutrients       Date:  2016-01-20       Impact factor: 5.717

10.  Combined Association of Vitamin D and Sex Hormone Binding Globulin With Nonalcoholic Fatty Liver Disease in Men and Postmenopausal Women: A Cross-Sectional Study.

Authors:  Ningjian Wang; Hualing Zhai; Chaoxia Zhu; Qin Li; Bing Han; Yi Chen; Chunfang Zhu; Yingchao Chen; Fangzhen Xia; Dongping Lin; Yingli Lu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.